Angels Bank On Patented Milk Ingredient Creaming It In International Markets/private heal

Dr Claycomb says the $500,000 will be used by the company to grow global sales of IDP® and reach Quantecs next milestone of testing its formulation as a mastitis treatment in cows.

Allowed HTML tags: <p> <br> <ul> <ol> <li> <em> <b> <u> <i> <strong>

Additionally, the Waikato Innovation Park has helped us through their Greenfield Investment Group. AngelLink is an accredited Seed Co-investment Partner of NZVIF and have been hugely supportive. Plus, our broker, Deloitte, has worked hard for us for over two years to get this investment across the line. Its definitely been a regional effort to make this deal happen, says Dr Claycomb.

Angels Bank On Patented Milk Ingredient Creaming It In International Markets/private heal,Quantec specialises in discovering and commercialising high-value bioactives from natural products. These bioactives are then developed into ingredients used in human and animal health products.

Links will open on

The first human health products incorporating our ingredient, known as IDPTM, should be on the shelves in both the US and China by mid-year. They will be products such as breath mints and gums that kill germs in the mouth and creams that sooth inflamed skin conditions.

Links will take you to

Dr Claycomb confirmed he has had preliminary discussions with animal health companies interested in the companys mastitis work.

The latest money guides from authoritative New Zealand sources: Investing, KiwiSaver & Saving, Managing Money, Home Loans, Credit Cards, Tax.

Quantec co-founder and Senior Scientist, Dr Judy BAngels Bank On Patented Milk Ingredient Creaming It In International Markets/private healragger, explains that the really big win for Quantec will come if we can crack the animal health market. For five years, Quantec has been working on a non-antibiotic, natural treatment for mastitis. Mastitis is the number one animal health issue in the dairy industry worldwide, and our aim is to develop an effective natural treatment that doesnt require milk withholding by rmers.

Waikato-based private equity fund, Central Capital Investments, announced today it has backed Hamilton-based company, Quantec Limited, with a $250,000 cash injection. The funds investment has been matched by the Governments New Zealand Venture Investment Fund (NZVIF) for a total outlay of $500,000.

Over the past two years, Quantec has pitched to investors both in New Zealand and overseas, so its been great to secure backing from private investors who are all from the Waikato region.

Our milk-derived fraction comes from the same system that cows milk has to naturally fight mastitis in her mammary gland. Our research has now proven IDPTM can completelyprivate health fund kill mastitis organisms on the lab bench. Now the plan is to take our research into the field and test our formulation inside the animal.

The $500,000 investment into Quantec was made possible by a host of Waikato-based organisations.

All articles and comments on have been submitted by our community of users. Please notify us through our contact form if you believe an item on this site breaches our community guidelines.

Health Tips, Recommended Movies, Recommended Books, Recommended Places.

Quantec co-founder and Managing Director, Dr Rod Claycomb, says our companys first product is a novel milk-derived fraction that has proven anti-inflammatory, antioxidant and antimicrobial properties.

You can change the deult for this field in Comment follow-up notification settings on your account edit page.

Leave a Reply